Eye drops could be a more effective -- and comfortable -- therapy for a common eye disease currently treated with injections into the eye, suggests a study.

Retinal vein occlusion (RVO), an eye disease that affects up to 2 per cent of people over age 40, occurs when a vein in the eye's retina becomes blocked, leading to swelling in the eye, inflammation, damage to the retina, and vision loss.